Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Marks

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Biochemical and Biophysical Research Communications|June 16, 1980
Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycleR Gambari, E Fibach, R A Rifkind, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitmentT Murate, T Kaneda, R A Rifkind, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|June 1, 1984
Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBAX Bin, M DiLiberto, R A Rifkind, et al.
Biochimica Et Biophysica Acta|June 17, 1971
Cold-induced accumulation of ribosomal subunits from human reticulocytesJ E Fuhr, C Natta, A Bank, et al.
Journal of Molecular Biology|June 14, 1970
Erythroid cell development in fetal mice: stabilization of the hemoglobin synthetic capacityM Djaldetti, D Chui, P A Marks, et al.
Cancer Research|February 1, 1977
Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cellsE Fibach, R C Reuben, R A Rifkind, et al.
Blood Cells, Molecules & Diseases|May 19, 2001
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancersV M Richon, X Zhou, R A Rifkind, et al.
Molecular and Cellular Biology|November 1, 1994
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cellsH Kiyokawa, V M Richon, R A Rifkind, et al.
Current Opinion in Oncology|October 24, 2001
Histone deacetylase inhibitors as new cancer drugsP A Marks, V M Richon, R Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell divisionR G Ramsay, K Ikeda, R A Rifkind, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Biochemical and Biophysical Research Communications|June 16, 1980
Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycleR Gambari, E Fibach, R A Rifkind, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitmentT Murate, T Kaneda, R A Rifkind, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|June 1, 1984
Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBAX Bin, M DiLiberto, R A Rifkind, et al.
Biochimica Et Biophysica Acta|June 17, 1971
Cold-induced accumulation of ribosomal subunits from human reticulocytesJ E Fuhr, C Natta, A Bank, et al.
Journal of Molecular Biology|June 14, 1970
Erythroid cell development in fetal mice: stabilization of the hemoglobin synthetic capacityM Djaldetti, D Chui, P A Marks, et al.
Cancer Research|February 1, 1977
Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cellsE Fibach, R C Reuben, R A Rifkind, et al.
Blood Cells, Molecules & Diseases|May 19, 2001
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancersV M Richon, X Zhou, R A Rifkind, et al.
Molecular and Cellular Biology|November 1, 1994
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cellsH Kiyokawa, V M Richon, R A Rifkind, et al.
Current Opinion in Oncology|October 24, 2001
Histone deacetylase inhibitors as new cancer drugsP A Marks, V M Richon, R Breslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell divisionR G Ramsay, K Ikeda, R A Rifkind, et al.
Pageof 19